SAN DIEGO — July 8, 2025 — Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced the promotion of Alex Slater to Chief Business Officer, reinforcing the company’s commitment to advancing commercial excellence and client-centric growth.
Alex Slater has been with Crown Bioscience since 2021, most recently serving as Senior Vice President of Commercial, where he played a pivotal role in driving the company’s commercial strategy across APAC, EMEA, and the US. Throughout his tenure, Alex has led the business development function, helping to expand Crown Bioscience’s market presence and deliver innovative solutions to clients worldwide.
“Since joining Crown Bioscience, Alex has demonstrated strong leadership and strategic focus, successfully aligning our commercial organization to meet an evolving market,” said John Gu, CEO of Crown Bioscience. “His promotion reflects our confidence in his ability to drive continued growth and further strengthen client partnerships worldwide.”
Commenting on his appointment, Alex Slater said, “I’m honored to step into the Chief Business Officer role. Working alongside this exceptional team has been a privilege, and this milestone reflects the collective effort of everyone at Crown Bioscience. I look forward to building on our achievements as we continue to unlock new opportunities, deliver exceptional science, and expand our impact for clients and patients alike.”
The promotion comes as Crown Bioscience continues to strengthen in its global capabilities, including recent investments in laboratory infrastructure and the expansion of its preclinical platforms and service offerings.
For more information on the Crown Bioscience leadership, click here.
Media Inquiries:
Crown Bioscience
Sarah Martin-Tyrrell
pr@crownbio.com
